Gary Borzillo

Gary Borzillo is a seasoned molecular and cell biologist specializing in oncology translational research with extensive experience in drug development. Currently, they serve as the Director of Clinical Sciences at Johnson & Johnson, where they lead translational strategies for antibody-drug conjugates in prostate cancer and oversee collaborations in cancer interception. Their career spans over three decades in the biotech and pharmaceutical industries, including significant roles at Lilly and Pfizer, where they contributed to multiple oncology programs. Gary holds a PhD in Molecular Cell Biology from The University of Alabama at Birmingham and has been involved in various academic collaborations and mentorship initiatives throughout their career.